Table 1

Demographics and clinical characteristics of patients with classic acute macular neuroretinopathy (AMN)

No.AgeEyeStudy eyeSexF/u yearsBaseline BCVABCVA last visitMedication taken during onset of symptoms possibly associated with AMNAssociated/causative findings
137ODODm2.2OD:20/200
OS:20/20
OD:20/20
OS:20/20
None.Car accident.
225OUOSf0.6OD:20/50
OS:20/80
OD:20/25
OS:20/25
None.Unknown.
317OSOSf1.3OD:20/16
OS:20/16
OD:20/16
OS:20/16
None.Unknown.
436OSOSf1.1OD:20/25
OS:20/20
OD:20/20
OS:20/20
None.SAB, accident.
527OSOSf0.2OD:20/20
OS:20/20
OD:20/20
OS:20/20
None.Unknown.
627OUODf1.4OD:20/16
OS:20/16
OD:20/16
OS:20/16
None.Fever 1 day before onset.
725OUODf0.4OD:20/20
OS:20/20
OD:20/20
OS:20/20
None.Viral infection.
824ODODf0.6OD:20/16
OS:20/16
OD:20/16
OS:20/16
None.Unknown.
924OSOSf0.2OD:20/20
OS:20/20
OD:20/20
OS:20/20
None.Unknown.
1022OUOSf3.7OD: 20/20
OS: 20/20
OD:20/20
OS:20/20
Oral contraceptives.Influenza-like symptoms.
11*25OUODf0.6OD:20/32
OS:20/20
OD:20/20
OS:20/20
Intravenous rabbit antithymocyte globulin, oral contraceptives.Oxalosis type 1, H.o. kidney and liver Tx.
  • Study eyes are shown in bold.

  • *Munch et al.26

  • Eye, eyes presenting with AMN lesions at baseline; study eye, eye included in the analyses; OD, right eye; OS, left eye; OU, both eyes; F/u, follow-up; BCVA, best corrected visual acuity; SAB, subarachnoidal bleeding; H.o., history of; Tx, transplantation.